Insider sale
WEREWOLF THERAPEUTICS, INC.
$28.4K
87.92K shares
What this filing means
UBS ONCOLOGY IMPACT FUND L.P. plans to sell 87.92K shares of WEREWOLF THERAPEUTICS, INC. valued at approximately $28.4K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 6/29/2026ACC: 0001628280-26-046084
10% Owner
Since Apr 2021
87.92K
Shares to sell
$28.4K
Approx. market value
87.92K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Private Placement
Cash
5/4/2021
87.92KTotal acquired87.92K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
5/4/2021 | Private Placement Cash | 87.92K | — |
| Total | 87.92K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
87.92K
Market value
$28.4K
6/29/2026
Total
Units
87.92K
Value
$28.4K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
6/29/2026 | 87.92K | $28.4K | NASDAQ | Planned |
| Total | 87.92K | $28.4K | ||